Pharmaceutical - Aspen Pharmacare

Filter

Current filters:

Aspen Pharmacare

Popular Filters

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Aspen Pharma reports rise in profits from new product launches

11-09-2013

South Africa's leading drugmaker Aspen Pharmacare (APN: SJ) has released financial results which show…

ArixtraAspen PharmacareFinancialFraxiparineGlaxoSmithKlineMerck & CoPharmaceuticalRest of the World

Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site

19-06-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

South Africa's drugmakers bemoan low medicine price hikes

27-01-2013

South Africa's Department of Health announced last week that pharmaceutical companies will be allowed…

Adcock IngramAspen PharmacareGenericsPharmaceuticalPricingRest of the World

Aspen Pharmacare acquires portfolio from GSK in Australia for £172 million

15-08-2012

South Africa headquartered Aspen Pharmacare (APN: SJ) revealed this morning that it has reached agreement…

Asia-PacificAspen PharmacareGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Company Spotlight

ImmunoGen

ImmunoGen

Back to top